Your browser doesn't support javascript.
loading
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells.
Thaker, Youg R; Rivera, Ianne; Pedros, Christophe; Singh, Alok R; Rivero-Nava, Laura; Zhou, Heyue; Swanson, Barbara A; Kerwin, Lisa; Zhang, Yanliang; Gray, J Dixon; Kaufmann, Gunnar F; Ji, Henry; Allen, Robert D; Bresson, Damien.
Afiliação
  • Thaker YR; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Rivera I; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Pedros C; Janssen, San Diego, CA, United States.
  • Singh AR; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Rivero-Nava L; Turnstone Biologics, Center for Novel Therapeutics, La Jolla, CA, United States.
  • Zhou H; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Swanson BA; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Kerwin L; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Zhang Y; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Gray JD; Retired, Encinitas, CA, United States.
  • Kaufmann GF; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Ji H; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Allen RD; Sorrento Therapeutics, Inc., San Diego, CA, United States.
  • Bresson D; Sorrento Therapeutics, Inc., San Diego, CA, United States.
Front Oncol ; 12: 884196, 2022.
Article em En | MEDLINE | ID: mdl-35664753
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos